Jagsonpal Pharmaceuticals Limited
JAGSNPHARM
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Sept 202681
Quarter ₹ crore YoY Sept 2024 75 +29.2% Dec 2024 74 +56.7% Mar 2025 59 +34.7% Jun 2025 76 +23.1% Sept 2025 74 -0.3% Dec 2025 73 -1.5% Mar 2026 64 +9.6% Jun 2026 82 +8.8% Sept 2026 81 +9.3% - ₹ crore
Sept 20262
Quarter ₹ crore Sept 2024 2 Dec 2024 2 Mar 2025 3 Jun 2025 3 Sept 2025 3 Dec 2025 3 Mar 2026 3 Jun 2026 3 Sept 2026 2 - ₹ crore
Sept 202684
Quarter ₹ crore Sept 2024 76 Dec 2024 76 Mar 2025 61 Jun 2025 78 Sept 2025 77 Dec 2025 76 Mar 2026 67 Jun 2026 85 Sept 2026 84 - Cost structure
- ₹ crore
Sept 202622
Quarter ₹ crore Sept 2024 17 Dec 2024 18 Mar 2025 17 Jun 2025 19 Sept 2025 18 Dec 2025 18 Mar 2026 16 Jun 2026 23 Sept 2026 22 - ₹ crore
Sept 202667
Quarter ₹ crore Sept 2024 61 Dec 2024 61 Mar 2025 52 Jun 2025 64 Sept 2025 61 Dec 2025 59 Mar 2026 56 Jun 2026 67 Sept 2026 67 - Exceptional items and tax
- ₹ crore
Sept 202617
Quarter ₹ crore Sept 2024 15 Dec 2024 39 Mar 2025 9 Jun 2025 14 Sept 2025 17 Dec 2025 15 Mar 2026 12 Jun 2026 18 Sept 2026 17 - ₹ crore
Sept 20264
Quarter ₹ crore Sept 2024 4 Dec 2024 7 Mar 2025 2 Jun 2025 4 Sept 2025 4 Dec 2025 4 Mar 2026 3 Jun 2026 4 Sept 2026 4 - Profit
- ₹ crore
Sept 202613
Quarter ₹ crore YoY Sept 2024 11 +53.4% Dec 2024 32 +707.2% Mar 2025 7 +85.5% Jun 2025 11 +102.6% Sept 2025 13 +9.7% Dec 2025 11 -65.8% Mar 2026 9 +33.1% Jun 2026 13 +22.2% Sept 2026 13 +0.1% - Per share
- ₹ per share
Sept 20261.91
Quarter ₹ per share Sept 2024 4.29 Dec 2024 4.74 Mar 2025 0.98 Jun 2025 1.60 Sept 2025 1.88 Dec 2025 1.67 Mar 2026 1.25 Jun 2026 2.00 Sept 2026 1.91 - Leverage
Debt to equity
timesJun 20250.00x
Quarter times Sept 2024 — Dec 2024 0.00x Mar 2025 0.00x Jun 2025 0.00x Sept 2025 — Dec 2025 — Mar 2026 — Jun 2026 — Sept 2026 —
| ₹ crore | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 75 | 74 | 59 | 76 | 74 | 73 | 64 | 82 | 81 | |
| Revenue YoY | +29.2% | +56.7% | +34.7% | +23.1% | -0.3% | -1.5% | +9.6% | +8.8% | +9.3% |
| 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | |
| 76 | 76 | 61 | 78 | 77 | 76 | 67 | 85 | 84 | |
| Cost structure | |||||||||
| 17 | 18 | 17 | 19 | 18 | 18 | 16 | 23 | 22 | |
| 61 | 61 | 52 | 64 | 61 | 59 | 56 | 67 | 67 | |
| Exceptional items and tax | |||||||||
| 15 | 39 | 9 | 14 | 17 | 15 | 12 | 18 | 17 | |
| 4 | 7 | 2 | 4 | 4 | 4 | 3 | 4 | 4 | |
| Profit | |||||||||
| 11 | 32 | 7 | 11 | 13 | 11 | 9 | 13 | 13 | |
| Net profit YoY | +53.4% | +707.2% | +85.5% | +102.6% | +9.7% | -65.8% | +33.1% | +22.2% | +0.1% |
| Per share | |||||||||
| 4.29 | 4.74 | 0.98 | 1.60 | 1.88 | 1.67 | 1.25 | 2.00 | 1.91 | |
| Leverage | |||||||||
| Debt to equity | — | 0.00x | 0.00x | 0.00x | — | — | — | — | — |
Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.